GB1174854A - New Biologically Active Conjugates - Google Patents

New Biologically Active Conjugates

Info

Publication number
GB1174854A
GB1174854A GB31374/67A GB3137467A GB1174854A GB 1174854 A GB1174854 A GB 1174854A GB 31374/67 A GB31374/67 A GB 31374/67A GB 3137467 A GB3137467 A GB 3137467A GB 1174854 A GB1174854 A GB 1174854A
Authority
GB
United Kingdom
Prior art keywords
extract
acid
biologically active
pollen extract
naja
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB31374/67A
Other languages
English (en)
Inventor
Patrick James Mill
Michael Alan Cresswell
Joseph George Feinberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Laboratories Inc filed Critical Miles Laboratories Inc
Priority to GB31374/67A priority Critical patent/GB1174854A/en
Priority to IL30258A priority patent/IL30258A/en
Priority to CH998868A priority patent/CH526590A/de
Priority to FR1584763D priority patent/FR1584763A/fr
Priority to NL6809538.A priority patent/NL160723C/xx
Priority to DE1768841A priority patent/DE1768841C3/de
Priority to LU56423D priority patent/LU56423A1/xx
Priority to BE717689D priority patent/BE717689A/xx
Priority to SE6809321A priority patent/SE383100B/xx
Priority to ES355853A priority patent/ES355853A1/es
Priority to FR168874A priority patent/FR7784M/fr
Publication of GB1174854A publication Critical patent/GB1174854A/en
Priority to US05/278,880 priority patent/US4003792A/en
Priority to SE7511288A priority patent/SE400652B/xx
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB31374/67A 1967-07-01 1967-07-07 New Biologically Active Conjugates Expired GB1174854A (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GB31374/67A GB1174854A (en) 1967-07-07 1967-07-07 New Biologically Active Conjugates
IL30258A IL30258A (en) 1967-07-07 1968-06-26 New conjugates of acid polysaccharides and complex organic substances
CH998868A CH526590A (de) 1967-07-07 1968-07-04 Verfahren zur Herstellung von Amiden und deren Salzen aus einem sauren Polysaccharid und komplexen, Aminogruppen enthaltenden organischen Verbindungen
BE717689D BE717689A (enrdf_load_stackoverflow) 1967-07-07 1968-07-05
NL6809538.A NL160723C (nl) 1967-07-07 1968-07-05 Werkwijze voor het bereiden van een immunolo- gisch actieve organische verbinding.
DE1768841A DE1768841C3 (de) 1967-07-07 1968-07-05 Kovalent gebundene Konjugate von sauren Polysacchariden und komplexen organischen Stoffen
LU56423D LU56423A1 (enrdf_load_stackoverflow) 1967-07-07 1968-07-05
FR1584763D FR1584763A (enrdf_load_stackoverflow) 1967-07-07 1968-07-05
SE6809321A SE383100B (sv) 1967-07-07 1968-07-05 Forfarande for framstellning av immunologiskt aktiva konjugat av allergener eller giftemnen med sura polysackarider
ES355853A ES355853A1 (es) 1967-07-07 1968-07-06 Un procedimiento para preparar un conjugado de un polisaca-rido acido y de una sustancia proteinica bioquimicamente ac-tiva.
FR168874A FR7784M (enrdf_load_stackoverflow) 1967-07-07 1968-10-04
US05/278,880 US4003792A (en) 1967-07-01 1972-08-08 Conjugates of acid polysaccharides and complex organic substances
SE7511288A SE400652B (sv) 1967-07-07 1975-10-08 Sett att framstella konjugat av insulin med sura polysackarider

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31374/67A GB1174854A (en) 1967-07-07 1967-07-07 New Biologically Active Conjugates

Publications (1)

Publication Number Publication Date
GB1174854A true GB1174854A (en) 1969-12-17

Family

ID=10322153

Family Applications (1)

Application Number Title Priority Date Filing Date
GB31374/67A Expired GB1174854A (en) 1967-07-01 1967-07-07 New Biologically Active Conjugates

Country Status (10)

Country Link
BE (1) BE717689A (enrdf_load_stackoverflow)
CH (1) CH526590A (enrdf_load_stackoverflow)
DE (1) DE1768841C3 (enrdf_load_stackoverflow)
ES (1) ES355853A1 (enrdf_load_stackoverflow)
FR (2) FR1584763A (enrdf_load_stackoverflow)
GB (1) GB1174854A (enrdf_load_stackoverflow)
IL (1) IL30258A (enrdf_load_stackoverflow)
LU (1) LU56423A1 (enrdf_load_stackoverflow)
NL (1) NL160723C (enrdf_load_stackoverflow)
SE (2) SE383100B (enrdf_load_stackoverflow)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003792A (en) 1967-07-01 1977-01-18 Miles Laboratories, Inc. Conjugates of acid polysaccharides and complex organic substances
DE3032488A1 (de) * 1979-09-05 1981-04-02 Kabushiki Kaisha Hayashibara, Seibutsu-Kagaku Kenkyujo, Okayama Verfahren zur herstellung eines impfstoffs
US4663287A (en) * 1983-06-15 1987-05-05 Gist-Brocades N.V. Biologically active conjugates and their preparation and use
GB2270920A (en) * 1992-09-25 1994-03-30 Univ Keele Alginate-bioactive agent conjugates
US5384256A (en) * 1992-04-25 1995-01-24 Nestec S.A. Pectin-modified lipase from Mucor javanicus with lowered saturated/unsaturated fatty acid ratio
US5393538A (en) * 1992-04-25 1995-02-28 Nestec S.A. Preparation of crumb-flavored milk chocolate

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1243832A (en) * 1968-10-25 1971-08-25 Beecham Group Ltd Vaccines
US3957580A (en) * 1974-03-27 1976-05-18 Pfizer Inc. Immobilized microbial cells
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
DE3443877A1 (de) * 1984-06-09 1985-12-12 Hoechst Ag Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung
IT1203814B (it) * 1986-06-30 1989-02-23 Fidia Farmaceutici Esteri dell'acido alginico
FR2817870B1 (fr) * 2000-12-08 2006-07-28 Skw Nature Products Holding Fr Polymeres conjugues a base de pectines et leur application comme emulsifiants

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003792A (en) 1967-07-01 1977-01-18 Miles Laboratories, Inc. Conjugates of acid polysaccharides and complex organic substances
DE3032488A1 (de) * 1979-09-05 1981-04-02 Kabushiki Kaisha Hayashibara, Seibutsu-Kagaku Kenkyujo, Okayama Verfahren zur herstellung eines impfstoffs
US4663287A (en) * 1983-06-15 1987-05-05 Gist-Brocades N.V. Biologically active conjugates and their preparation and use
US5384256A (en) * 1992-04-25 1995-01-24 Nestec S.A. Pectin-modified lipase from Mucor javanicus with lowered saturated/unsaturated fatty acid ratio
US5393538A (en) * 1992-04-25 1995-02-28 Nestec S.A. Preparation of crumb-flavored milk chocolate
GB2270920A (en) * 1992-09-25 1994-03-30 Univ Keele Alginate-bioactive agent conjugates
GB2270920B (en) * 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
US5622718A (en) * 1992-09-25 1997-04-22 Keele University Alginate-bioactive agent conjugates

Also Published As

Publication number Publication date
NL160723B (nl) 1979-07-16
SE383100B (sv) 1976-03-01
BE717689A (enrdf_load_stackoverflow) 1968-12-16
FR1584763A (enrdf_load_stackoverflow) 1970-01-02
DE1768841A1 (de) 1971-11-18
DE1768841B2 (de) 1980-01-31
ES355853A1 (es) 1970-03-01
DE1768841C3 (de) 1980-09-25
IL30258A (en) 1972-02-29
CH526590A (de) 1972-08-15
FR7784M (enrdf_load_stackoverflow) 1970-03-23
NL160723C (nl) 1979-12-17
LU56423A1 (enrdf_load_stackoverflow) 1968-10-21
SE7511288L (sv) 1975-10-08
SE400652B (sv) 1978-04-03
NL6809538A (enrdf_load_stackoverflow) 1969-01-09

Similar Documents

Publication Publication Date Title
GB1174854A (en) New Biologically Active Conjugates
US4003792A (en) Conjugates of acid polysaccharides and complex organic substances
Anderson et al. Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197.
CA2215933C (en) Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
US5425946A (en) Vaccines against group C Neisseria meningitidis
CA2556169C (en) Use of amino-oxy functional groups in the preparation of vaccines
JPH01500036A (ja) 免疫原性複合体
JPH0222234A (ja) 多糖類‐タンパク質複合体
AU740784B2 (en) Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines
EP0625910A1 (en) Dual carrier immunogenic construct
CN104755102A (zh) 多价肺炎球菌多糖-蛋白质结合物组合物
HRP20030598A2 (en) Multivalent meningococcal polysaccharide-protein conjugate vaccine of depression and/or anxiety and compounds useful
US4372883A (en) Process for the production of vaccine
US20020009463A1 (en) Novel, non-antigenic, mucosal adjuvant formulation which enhances the effects of substances, including vaccine antigens, in contact with mucosal body surfaces
Pawlowski et al. A new method of non-cross-linking conjugation of polysaccharides to proteins via thioether bonds for the preparation of saccharide–protein conjugate vaccines
Fattom et al. Synthesis and physicochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates
DE69922990T2 (de) Herstellungsverfahren von festphasekonjugateimpfstoffen
JPH0674211B2 (ja) Ｂ群ＩａＩｃ型連鎖状球菌特異性多糖抗原
GB1218277A (en) Dry water-dispersible aluminium hydroxide gels
Lambden et al. Synthesis of immunogenic oligosaccharide-protein conjugates from the lipopolyasaccharide of Neisseria Gonorrhoeae P9
Chetty et al. Soluble peptidoglycan-polysaccharide fragments of the bacterial cell wall induce acute inflammation
US5460832A (en) Skin cosmetic having an egg white enzyme hydrolysate with hyaluronic acid synthesis promoting activity
DE68915046T2 (de) Haemophilus influenzae Typ B Polysaccharid-Aussermembranprotein-Konjugat als Impfstoff.
CN101107010A (zh) 经修饰的链球菌多糖及其用途
US3577523A (en) Water-insoluble antigenic substances and method of preparing the same and antigenic depot agents incorporating such substances

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years